According to one study, pioglitazone is an antidiabetic that prevents gallstone formation, liver damage, and gallbladder damage, and guinea pigs treated with pioglitazone showed beneficial changes in the biliary cholesterol and bile acids, blood glucose, insulin, and lipid distribution (24). The gene discussed is INS; the disease is gallstones.